Immunotherapy

Side effects of PI3Kδ immunotherapy could be mitigated by changing drug dosing

Two recent studies add significant evidence toward understanding the cause of MS

New study finds blood biomarkers that help indicate the effectiveness of immune checkpoint inhibitors

Off-the-shelf allogeneic T-cell therapies have the potential to leverage the power of a healthy donor’s immune system

The findings pave the way for prospective clinical trials designed to test whether this biomarker can improve outcomes

How the IsoLight/IsoSpark can support a research lab’s pursuit of novel immunotherapies

Consider these key factors for a successful, reproducible flow cytometry assay

Single-cell proteomics can predict resistance and enable therapies to combat drug-resistant cell states

Functional proteomics provides a complete picture of the mechanisms involved in the patient response

Research shows bacteria residing within tumors can be harnessed to provoke an immune reaction against the tumor